⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AKBA News
Akebia Therapeutics, Inc.
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
AKBA
Akebia Announces Establishment of Rare Kidney Disease Pipeline
globenewswire.com
AKBA
QTTB
Q32 Bio Sells Complement Inhibitor ADX-097
prnewswire.com
QTTB
AKBA
ATTENTION Akebia Therapeutics, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights
accessnewswire.com
AKBA
Akebia Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
globenewswire.com
AKBA
Shareholders that lost money on Akebia Therapeutics, Inc.(AKBA) should contact Levi & Korsinsky about Securities Fraud Investigation - AKBA
accessnewswire.com
AKBA
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Akebia Therapeutics, Inc. (AKBA)
accessnewswire.com
AKBA
ATTENTION AKBA SHAREHOLDERS: Investors who lost money on Akebia Therapeutics, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation
accessnewswire.com
AKBA
Akebia Therapeutics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - AKBA
accessnewswire.com
AKBA
Levi & Korsinsky Announces an Investigation on Behalf of Akebia Therapeutics, Inc. (AKBA) Shareholders Who May Have Been Affected by Fraud
accessnewswire.com
AKBA